870602P
Avanti
PGPC
Avanti Research™ - A Croda Brand 870602P, powder
Synonym(s):
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
form
powder
packaging
pkg of 1 × 1 mg (870602P-1mg)
pkg of 1 × 5 mg (870602P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 870602P
shipped in
dry ice
storage temp.
−20°C
SMILES string
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCC(O)=O)=O)COC(CCCCCCCCCCCCCCC)=O)=O
General description
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine (PGPC) is a constituent of oxidatively modified low density lipoproteins (oxLDLs). It is synthesized from the non-enzymatic oxidation of a major low-density lipoproteins (LDL) phospholipid, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PAPC).
Application
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine (PGPC) has been used to study its effect on plasma membrane nanoplatforms using single-molecule microscopy.
Biochem/physiol Actions
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine (PGPC) acts as an inducer of inflammation, proliferation or apoptosis in cultured vascular smooth muscle cells and macrophages. It is accumulated in atherosclerotic lesions.
Packaging
5 mL Clear Glass Sealed Ampule (870602P-1mg)
5 mL Clear Glass Sealed Ampule (870602P-5mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1761(9), 1060-1069 (2006)
The role of high-density lipoproteins in oxidation and inflammation
Trends in Cardiovascular Medicine, 11(3-4), 155-161 (2001)
Oxidized phospholipids inhibit the formation of cholesterol-dependent plasma membrane nanoplatforms
Biophysical Journal, 110(1), 205-213 (2016)
Journal of lipid research, 48(3), 565-582 (2006-12-01)
Lipid oxidation is now thought to be an initiating and sustaining event in atherogenesis. Oxidatively fragmented phospholipids, namely 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC), present in minimally modified LDL and atherosclerotic lesions, have been reported to elicit a wide range of
Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms.
Biophysical journal, 110(1), 205-213 (2016-01-09)
We previously developed a single-molecule microscopy method termed TOCCSL (thinning out clusters while conserving stoichiometry of labeling), which allows for direct imaging of stable nanoscopic platforms with raft-like properties diffusing in the plasma membrane. As a consensus raft marker, we
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service